Abstract:Objective: Breast cancer (BC) is the most commonly diagnosed cancer among females and has a poor prognosis, breast invasive ductal carcinoma is the most common histological type. The occurrence and development of BC is closely related to aberrant glucose metabolism. In the hyperglycemic environment caused by abnormal glucose metabolism, hypoxia-inducible factor-1 alpha (HIF-1 alpha) enables tumor cells to absorb large amounts of glucose and enhance glycolysis by inducing the expression of glucose transporter type1 (GLUT1) and glycolysis genes, thus promoting tumor cell proliferation and metastasis. Mitochondrial Sirtuin5 (SIRT5) plays a role in the rewiring of glucose metabolism during the progression of cancers. Thus, we aimed to elucidate whether SIRT5 promotes BC proliferation and metastasis by facilitating aerobic glycolysis in BC. Methods: The expression of SIRT5 in breast carcinoma tissue and cells was evaluated using immunohistochemical staining, western blot and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis to confirm the biological role of SIRT5 in breast carcinoma. We established a stable cell line with SIRT5 knockdown using lentiviral transduction in T47D cells to reduce SIRT5 expression and then evaluated the effect of SIRT5 on cells cultured in the presence of high glucose (4500 mg/L) and normal glucose (2000 mg/L) concentrations. Cell proliferation was detected using the CCK-8 assay, the cell cycle and cell apoptosis were measured using flow cytometry and Annexin V staining, and cell migration was tested by performing Celigo scratch and Transwell assays. The expression of PKM2, HK2, mTOR and HIF-1 alpha, which play roles in aerobic glycolysis, was investigated using western blot. Results: SIRT5 was overexpressed in BC tissues compared with paired normal tissues. Prognostic and OS analyses showed that the SIRT5 expression level was an individual prognostic factor for patients with BC. SIRT5 knockdown inhibited proliferation and metastasis and slightly increased apoptosis in T47D cells under highglucose conditions. Furthermore, the downregulation of HK2 and HIF-1 alpha caused by SIRT5 knockdown was a high glucose-dependent process, while the downregulation of PKM2 was mediated by a high glucoseindependent process. Conclusions: SIRT5 is an independent prognostic factor for BC and contributes to cell proliferation and metastasis in a high glucose-dependent manner to some degree, which might be mediated by promoting aerobic glycolysis.

SIRT3 Participates in Glucose Metabolism Interruption and Apoptosis Induced by BH3 Mimetic S1 in Ovarian Cancer Cells.

Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells.

Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress.

The Bh3 Mimetic S1 Induces Endoplasmic Reticulum Stress-Associated Apoptosis In Cisplatin-Resistant Human Ovarian Cancer Cells Although It Activates Autophagy

Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells

Sirt3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells

Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.

The BH3 Mimetic S1 Induces Autophagy Through ER Stress and Disruption of Bcl-2/Beclin 1 Interaction in Human Glioma U251 Cells

SIRT1 inhibits mitochondrial hyperfusion associated mito-bulb formation to sensitize oral cancer cells for apoptosis in a mtROS-dependent signalling pathway

SIRT 3 Enhances Glycolysis and Proliferation in SIRT 3-Expressing Gastric Cancer Cells

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer.

Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro

SIRT3 Increases Cisplatin Sensitivity of Small-Cell Lung Cancer Through Apoptosis.

SIK2 Promotes Reprogramming of Glucose Metabolism Through PI3K/AKT/HIF-1α Pathway and Drp1-mediated Mitochondrial Fission in Ovarian Cancer.

SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism

Sirt3 Is A Mitochondrial Tumor Suppressor: A Scientific Tale That Connects Aberrant Cellular Ros, The Warburg Effect, And Carcinogenesis

Sirt3 enhances glioma cell viability by stabilizing Ku70-BAX interaction

SIRT5 is Involved in the Proliferation and Metastasis of Breast Cancer by Promoting Aerobic Glycolysis.

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance